Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Intellia Therapeutics Inc (NTLA)

  • SEC News
  • Jan. 07, 2026, 21:05 UTC
  • 12
  • 1 comments

BASTA JAMES 🔴 sold 10.4K shares of Intellia Therapeutics, Inc. (NTLA) at $9.21 Transaction Date: Jan 05, 2026 | Filing ID: 006291

Comment Full text

Ironwood Pharmaceuticals Inc (IRWD)

  • SEC News
  • Jan. 07, 2026, 21:05 UTC
  • 11
  • 1 comments

Silver Ronald 🔴 sold 35.4K shares of IRONWOOD PHARMACEUTICALS INC (IRWD) at $4.60 Transaction Date: Jan 05, 2026 | Filing ID: 006290

Comment Full text

Sutro Biopharma Inc (STRO)

  • Business News
  • Jan. 07, 2026, 21:05 UTC
  • 15
  • 1 comments

Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Abivax (ABVX)

  • Business News
  • Jan. 07, 2026, 21:05 UTC
  • 12
  • 1 comments

Abivax Provides 2026 Corporate Outlook

Market reaction Comment Full text

Intellia Therapeutics Inc (NTLA)

  • SEC News
  • Jan. 07, 2026, 21:05 UTC
  • 11
  • 1 comments

Cohen Fred E 🟢 acquired 150.0K shares of Intellia Therapeutics, Inc. (NTLA) at $9.35 ($1.4M) Transaction Date: Jan 05, 2026 | Filing ID: 006288

Comment Full text

Solid Biosciences Inc (SLDB)

  • SEC News
  • Jan. 07, 2026, 21:05 UTC
  • 10
  • 1 comments

SMITH IAN F 🟡 adjusted position in 31.8K shares (3 derivative) of Solid Biosciences Inc. (SLDB) at $5.45 Transaction Date: Jan 02, 2026 | Filing ID: 006287

Comment Full text

Definitive Healthcare Corp (DH)

  • SEC News
  • Jan. 07, 2026, 21:05 UTC
  • 9
  • 1 comments

Heller Casey 🟢 acquired 195.3K shares of Definitive Healthcare Corp. (DH) Transaction Date: Jan 05, 2026 | Filing ID: 006286

Comment Full text

Definitive Healthcare Corp (DH)

  • Business News
  • Jan. 07, 2026, 21:05 UTC
  • 17
  • 1 comments

Definitive Healthcare to Present at the 28th Annual Needham Growth Conference

Market reaction Comment Full text

Phathom Pharmaceuticals Inc (PHAT)

  • Business News
  • Jan. 07, 2026, 21:05 UTC
  • 12
  • 1 comments

Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Market reaction Comment Full text

Annexon Inc (ANNX)

  • Business News
  • Jan. 07, 2026, 21:05 UTC
  • 16
  • 1 comments

Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Krystal Biotech (KRYS)

  • Business News
  • Jan. 07, 2026, 21:05 UTC
  • 16
  • 1 comments

Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis

Market reaction Comment Full text

Arcus Biosciences Inc. (RCUS)

  • Business News
  • Jan. 07, 2026, 21:05 UTC
  • 17
  • 1 comments

Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs

Market reaction Comment Full text

Ultragenyx Pharmaceutical Inc (RARE)

  • Business News
  • Jan. 07, 2026, 21:05 UTC
  • 13
  • 1 comments

Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

RAPT Therapeutics Inc (RAPT)

  • Business News
  • Jan. 07, 2026, 21:05 UTC
  • 9
  • 1 comments

RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Incyte Corporation (INCY)

  • SEC News
  • Jan. 07, 2026, 21:03 UTC
  • 8
  • 1 comments

Stein Steven H 🔴 sold 15.6K shares of INCYTE CORP (INCY) at $101.70 ($1.6M) Transaction Date: Jan 05, 2026 | Filing ID: 000004

Comment Full text
  • Previous
  • 541
  • 542
  • 543
  • 544
  • 545
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191985)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125295)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin